Cargando…

Cost Effectiveness of Different Initial Antimicrobial Regimens for Elderly Community-Acquired Pneumonia Patients in General Ward

PURPOSE: The cost-effectiveness of different guideline-concordant antimicrobial regimens for elderly patients with community-acquired pneumonia (CAP) was rarely discussed. This study attempts to explore the most appropriate cost-effectiveness of guideline-concordant antimicrobial regimen for elderly...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Xiudi, Chen, Liang, Wang, Yimin, Li, Hui, Wang, Hong, Xing, Xiqian, Zhang, Chunxiao, Suo, Lijun, Wang, Jinxiang, Yu, Guohua, Wang, Guangqiang, Yao, Xuexin, Yu, Hongxia, Wang, Lei, Liu, Xuedong, Cao, Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140887/ https://www.ncbi.nlm.nih.gov/pubmed/34040398 http://dx.doi.org/10.2147/IDR.S302852

Ejemplares similares

Effects of age, comorbidity and adherence to current antimicrobial guidelines on mortality in hospitalized elderly patients with community-acquired pneumonia
por: Han, Xiudi, et al.
Publicado: (2018)

Disease burden and prognostic factors for clinical failure in elderly community acquired pneumonia patients
por: Han, Xiudi, et al.
Publicado: (2020)

Prognostic Factors for Cardiovascular Events in Elderly Patients with Community Acquired Pneumonia: Results from the CAP-China Network
por: Han, Xiudi, et al.
Publicado: (2022)

Disease characteristics and management of hospitalised adolescents and adults with community-acquired pneumonia in China: a retrospective multicentre survey
por: Chen, Liang, et al.
Publicado: (2018)

Complications of Cardiovascular Events in Patients Hospitalized with Influenza-Related Pneumonia
por: Chen, Liang, et al.
Publicado: (2021)

The Clinical Characteristics and Outcomes of Adult Patients With Pneumonia Related to Three Paramyxoviruses
por: Chen, Liang, et al.
Publicado: (2021)

Invasive pulmonary aspergillosis in immunocompetent patients hospitalised with influenza A-related pneumonia: a multicenter retrospective study
por: Chen, Liang, et al.
Publicado: (2020)

The severity and risk factors for mortality in immunocompromised adult patients hospitalized with influenza-related pneumonia
por: Chen, Liang, et al.
Publicado: (2021)

Derivation and validation of a prediction rule for mortality of patients with respiratory virus-related pneumonia (RV-p score)
por: Chen, Liang, et al.
Publicado: (2020)

FluA-p score: a novel prediction rule for mortality in influenza A-related pneumonia patients
por: Chen, Liang, et al.
Publicado: (2020)

Comparison of clinical characteristics and outcomes between respiratory syncytial virus and influenza-related pneumonia in China from 2013 to 2019
por: Chen, Liang, et al.
Publicado: (2021)

Flu-IV score: a predictive tool for assessing the risk of invasive mechanical ventilation in patients with influenza-related pneumonia
por: Chen, Liang, et al.
Publicado: (2022)

The impact of early neuraminidase inhibitor therapy on clinical outcomes in patients hospitalised with influenza A-related pneumonia: a multicenter, retrospective study
por: Chen, Liang, et al.
Publicado: (2020)

Predictive Value of Annenxin A1 for Disease Severity and Prognosis in Patients with Community-Acquired Pneumonia
por: Gu, Minghao, et al.
Publicado: (2023)

Short-coupled variant of torsade de pointes: A systematic review of case reports and case series
por: Wang, Guangqiang, et al.
Publicado: (2022)

Antimicrobials: community-acquired pneumonia
Publicado: (2019)

Antimicrobial Treatment of Community-Acquired Pneumonia
por: Restrepo, Marcos I., et al.
Publicado: (2005)

Antimicrobial therapy of community-acquired pneumonia
por: File, Thomas M., et al.
Publicado: (2004)

Qualitative research on the work experience of pharmacists in fever clinics and isolation wards of designated hospitals for novel coronavirus pneumonia (COVID-19)
por: Hao, Jie, et al.
Publicado: (2021)

Antimicrobial Resistance and Clinical Outcomes in Nursing Home-Acquired Pneumonia, Compared to Community-Acquired Pneumonia
por: Kang, Yun-Seong, et al.
Publicado: (2017)

Development of a nomogram to estimate the risk of community‐acquired pneumonia in adults with acute asthma exacerbations
por: Duan, Yufan, et al.
Publicado: (2023)

Severe community-acquired pneumonia in general medical wards: outcomes and impact of initial antibiotic selection
por: Wongsurakiat, Phunsup, et al.
Publicado: (2019)

The Science of Selecting Antimicrobials for Community-Acquired Pneumonia (CAP)
por: File, Thomas M.
Publicado: (2009)

2586. Comparison of Antimicrobial Regimens for Critically Ill Patients with Suspected or Confirmed Hospital-Acquired or Ventilator-Associated Pneumonia: A Retrospective, Cohort Study
por: Kosharek, Abigail, et al.
Publicado: (2023)

Duration of Antimicrobial Therapy in Community Acquired Pneumonia: Less Is More
por: Pinzone, Marilia Rita, et al.
Publicado: (2014)

Advances in severe community-acquired pneumonia
por: Wang, Jian, et al.
Publicado: (2019)

Antimicrobial Resistance Analysis of Clinical Escherichia coli Isolates in Neonatal Ward
por: Wu, Dan, et al.
Publicado: (2021)

2193. Factors Impacting the Duration of Antimicrobial Therapy for Community-Acquired Pneumonia
por: Sandhu, Avnish, et al.
Publicado: (2019)

Influenza and Bacterial Coinfection in Adults With Community-Acquired Pneumonia Admitted to Conventional Wards: Risk Factors, Clinical Features, and Outcomes
por: Abelenda-Alonso, Gabriela, et al.
Publicado: (2020)

Mixed invasive pulmonary Mucor and Aspergillus infection: a case report and literature review
por: Teng, Peikun, et al.
Publicado: (2022)

Re-recognize early recurrence of persistent atrial fibrillation
por: Fu, Kaixuan, et al.
Publicado: (2023)

Chromosome-level genome assembly of Microplitis manilae Ashmead, 1904 (Hymenoptera: Braconidae)
por: Shu, Xiaohan, et al.
Publicado: (2023)

Prognostic value of severity indicators of nursing-home-acquired pneumonia versus community-acquired pneumonia in elderly patients
por: Ugajin, Motoi, et al.
Publicado: (2014)

COMMUNITY ACQUIRED PNEUMOCOCCAL PNEUMONIA IN NORTHWESTERN NIGERIA: EPIDEMIOLOGY, ANTIMICROBIAL RESISTANCE AND OUTCOME
por: Iliyasu, Garba, et al.
Publicado: (2017)

Childhood community-acquired pneumonia: A review of etiology- and antimicrobial treatment studies
por: Tramper-Stranders, Gerdien A.
Publicado: (2018)

Antimicrobial stewardship educational materials webinar series: community-acquired pneumonia (CAP)
Publicado: (2020)

1204. Evaluation Of An Antimicrobial Stewardship Scorecard For Hospitalized Patients With Community-Acquired Pneumonia
por: Klatt, Megan, et al.
Publicado: (2023)

Effect of an immunomodulatory regimen for cancer prevention: A case report
por: Wang, Wenbo, et al.
Publicado: (2016)

Mycoplasma pneumoniae and Adenovirus Coinfection Cause Pediatric Severe Community-Acquired Pneumonia
por: Li, Fei, et al.
Publicado: (2022)

Antimicrobial-Resistant Klebsiella pneumoniae Carriage and Infection in Specialized Geriatric Care Wards Linked to Acquisition in the Referring Hospital
por: Gorrie, Claire L, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_tjh2lh9kj41mrlggesf8v3hoot